CLINICAL_TRIALS
trial_result
· 2015-01-27
Clinical Trial Update: Rivastigmine and Huperzine A as Treatments for Cocaine Dependence [Phase 1]
Summary
This Phase 1 trial evaluated rivastigmine and huperzine A as potential treatments for cocaine use disorder, and the study status is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baylor College of Medicine | Conditions: Cocaine Dependence, Cocaine Addiction | Phase 1 | Status: COMPLETED